Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
K-Fast Holding AB: K-Fast Holding AB (publ): Year End report January-December 2024
Share transfer agreement signed with Brinova regarding divestment of our property portfolio in Region South. Payment will be made in the form of newly issued shares in Brinova which will make K-Fastig ...
Evaxion secures Nasdaq listing with equity boost
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company with a current market capitalization of $16.36 million, has confirmed its compliance with Nasdaq's minimum ...
Danske Bank A/S, transactions by persons discharging managerial responsibilities
Notification no. 10/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. For further details, please find the ...
Evaxion Biotech: Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination
Evaxion will remain listed on Nasdaq after successfully evidencing compliance with the Nasdaq minimum stockholders' equity requirement Evaxion has restored its equity above the minimum requirement thr ...
Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination
Evaxion will remain listed on Nasdaq after successfully evidencing compliance with the Nasdaq minimum stockholders’ equity requirement Evaxion has restored its equity above the minimum requirement ...
manilatimes16h
New share-based incentive program for members of management and certain key employees
With reference to GN's Remuneration Policy which was approved at the annual general meeting on March 13, 2024 and pursuant to which the long-term incentive program from 2025 onward will be based on ...
Genmab A/S schedules annual general meeting
COPENHAGEN, Denmark - Genmab A/S (NASDAQ:GMAB), a biotechnology company specializing in pharmaceutical preparations with a market capitalization of $12.2 billion and an impressive 95% gross profit ...
FirstFarms A/S: Reporting of transactions made by members of the Board of Directors or Executive Management or their closely associated persons
Pursuant to the Market Abuse Regulation, article 19, FirstFarms A/S, CVR-no. 28 31 25 04, (”FirstFarms”) hereby notifies receipt of information of the following transactions made by members of the ...
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results ...
Notice to Convene the Annual General Meeting of Genmab A/S
Company Announcement Genmab A/S to hold Annual General Meeting on Wednesday March 12, 2025 COPENHAGEN, Denmark; February 13, 2025 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on ...